Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
American Society of Clinical Oncology
Access Rights
info:eu-repo/semantics/closedAccess
DOI
Abstract
Description
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL
WOS: 000358613200461
WOS: 000358613200461
Keywords
Journal or Series
50th Annual Meeting of the American-Society-of-Clinical-Oncology
WoS Q Value
Scopus Q Value
Volume
32
Issue
15
Citation
Bilici, A., Selçukbiricik, F., Demir, N., Öven Ustaalioğlu, B. B., Dikillitaş, M. ve Yıldız, Ö. (2014). Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL: American Society of Clinical Oncology.
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
